| Literature DB >> 19143973 |
Anne Kotaniemi-Syrjänen1, Tiina M Reijonen, Kaj Korhonen, Matti Waris, Raija Vainionpää, Matti Korppi.
Abstract
BACKGROUND: Characteristics related to decreased lung function and increased bronchial responsiveness after early childhood wheezing requiring hospitalization are not fully established.Entities:
Mesh:
Year: 2008 PMID: 19143973 PMCID: PMC7167749 DOI: 10.1111/j.1442-200X.2008.02620.x
Source DB: PubMed Journal: Pediatr Int ISSN: 1328-8067 Impact factor: 1.524
Baseline lung function and responsiveness to exercise
| All children ( | |
|---|---|
| Baseline lung function parameters of FVS | |
| FVC | 103 (71–149) |
| FEV1 | 98 (66–135) |
| <80%, | 4 (5) |
| FEV1 FVC | 97 (76–115) |
| <88%, | 13 (16) |
| FEF50% | 88 (40–126) |
| <62%, | 14 (18) |
| Any subnormal FVS parameters | 18 (23) |
| Responsiveness to exercise (%) | |
| Fall in FEV1
| 2 (0–28) |
| ≥12%, | 10 (13) |
| ≥15%, | 5 (6) |
†% of the height‐related predicted value; ‡FEV1<80% or FEV1/FVC <88% or FEF50% <62% of the predicted value; §10 min after the exercise.
FEF50%, forced expiratory flow at 50% of the FVC; FEV1, forced expiratory flow in 1 s; FVC, functional vital capacity; FVS, flow‐volume spirometry.
Predictive factors for decreased lung function (n = 79)
| Outcome | Significant predictors of decreased lung function | No. children with the outcome | OR (95%CI) |
|---|---|---|---|
| FEV1 < 80% ( | Maternal smoking during pregnancy ( | 3 | 12.8 (1.2–139.6) |
| FEV1/FVC <88% ( | Parental history of asthma ( | 5 | 4.3 (1.1–17.1) |
| FEF50% < 62% ( | Female gender ( | 7 | 4.0 (1.2–13.7) |
| Any subnormal lung function parameters ( | Parental history of asthma ( | 7 | 4.4 (1.3–15.4) |
†Odds ratio adjusted for age (<12 months or ≥12 months on entry to the study) and gender; ‡% of the height‐related predicted value; §FEV1<80% or FEV1/FVC <88% or FEF50% < 62% of the predicted value.
CI, confidence interval; FEF50%, forced expiratory flow at 50% of the FVC; FEV1, forced expiratory flow in 1 s; FVC, functional vital capacity; FVS, flow‐volume spirometry; OR, odds ratio.
Early‐life predictors of increased bronchial responsiveness to exercise (n = 79)
| Outcome | Significant early‐life predictors of increased bronchial responsiveness | No. children with the outcome | OR (95%CI) |
|---|---|---|---|
| Fall in FEV ≥12% ( | |||
| Rhinovirus infection‐induced wheezing ( | 5 | 6.5 (1.2–36.3) | |
| Early exposure to cat/dog | |||
| Leading to sensitization ( | 2 | 26.6 (1.3–525.2) | |
| Leading to tolerance ( | 4 | 3.9 (0.7–20.0) | |
| Fall in FEV1≥15% ( | |||
| Rhinovirus infection‐induced wheezing ( | 4 | 18.5 (1.7–199.1) | |
†Odds ratio adjusted for age (<12 months or ≥12 months on entry to the study), gender, and the significant early‐life predictors of increased bronchial responsiveness; ‡cat and/or dog at home or at day care in infancy; §skin prick test positivity (wheal size ≥3 mm) to the animal in question (cat/dog) by school age; ¶compared to children with no exposure to cat/dog in infancy; ††skin prick test negativity (wheal size <3 mm) to the animal in question (cat/dog) at school age.
CI, confidence interval; FEV1, forced expiratory flow in 1 s; OR, odds ratio.
Lung function and responsiveness to exercise versus ongoing anti‐therapy (n = 79)
| Viral findings related to infantile wheezing |
| |||
|---|---|---|---|---|
| Rhinovirus only ( | Other/No virus ( | |||
| Decreased lung function | ||||
| Anti‐inflammatory therapy | No | 1 (5) | 8 (13) | 0.294 |
| Yes | 4 (21) | 5 (8) | ||
| Normal lung function | ||||
| Anti‐inflammatory therapy | No | 5 (26) | 36 (60) | 0.008 |
| Yes | 9 (47) | 11 (18) | ||
| Fall in FEV1≥12% after exercise | ||||
| Anti‐inflammatory therapy | No | 1 (5) | 5 (8) | 0.027 |
| Yes | 4 (21) | 0 (0) | ||
| Fall in FEV1 <12% after exercise | ||||
| Anti‐inflammatory therapy | No | 5 (26) | 39 (65) | 0.014 |
| Yes | 9 (47) | 16 (27) | ||
†FEV1 <80% or FEV1/FVC <88% or FEF50% <62% of the predicted value; ‡ongoing inhaled steroid or cromone therapy; §FEV1≥80% and FEV1/FVC ≥88% and FEF50%≥62% of the predicted value.
FEV1, forced expiratory flow in 1 s.